0001807120 2026-11-03 2026-11-03 0001807120 1 2026-11-03 2026-11-03 0001807120 2 2026-11-03 2026-11-03 0001807120 3 2026-11-03 2026-11-03 0001807120 4 2026-11-03 2026-11-03 0001807120 5 2026-11-03 2026-11-03 iso4217:USD pure S-3 S-3 EX-FILING FEES 0001807120 Design Therapeutics, Inc. N/A N/A 0.000087 0.000087 0.000087 0.000087 S-3 Design Therapeutics, Inc. Equity Common stock, par value $0.0001 per share true Equity Preferred stock, par value $0.0001 per share true Debt Debt Securities true Other Warrants true false Unallocated (Universal) Shelf true 300000000.00 0.000087 26100.00 300000000.00 26100.00 0.00 0.00 26100.00 There are being registered hereunder such indeterminate number of shares of common stock and preferred stock, such indeterminate principal amount of debt securities, and such indeterminate number of warrants to purchase common stock, preferred stock or debt securities as shall have an aggregate initial offering price not to exceed $300,000,000. If any debt securities are issued at an original issue discount, then the offering price of such debt securities shall be in such greater principal amount as shall result in an aggregate initial offering price not to exceed $300,000,000, less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or in combination with other securities registered hereunder. The securities registered also include such indeterminate amounts and numbers of common stock, preferred stock, and debt securities as may be issued upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the shares being registered hereunder include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. The proposed maximum offering price per share will be determined, from time to time, by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.iii.b. to the Calculation of Filing Fee Tables and Related Disclosure on Item 16(b) of Form S-3 under the Securities Act. Separate consideration may or may not be received for securities that are issuable upon the conversion or exercise of, or in exchange for, other securities offered hereby.